Analysis of the Interferon Gamma (rs2430561, +874T/A) Functional Gene Variant in Relation to the Presence of Cardiovascular Events in Rheumatoid Arthritis

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  García Bermúdez, Mercedes ^a   López Mejías, Raquel ^b   González Juanatey, Carlos ^c   Corrales, Alfonso ^b   Robledo, Gema ^a   Castañeda, Santos ^d   Miranda Filloy, José A ^c   Blanco, Ricardo ^b   Fernández Gutiérrez, Benjamín ^e   Balsa, Alejandro ^f   González Alvaro, Isidoro ^d   Gómez Vaquero, Carmen ^g   Llorca, Javier ^h   Martín, Javier ^a   González Gay, Miguel A ^b  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c HOSPITAL XERAL CALDE   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^h UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADULT; ALLELE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTERFERON GAMMA GENE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS;

ADULT; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84867507232     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047166     Document Type: Article

References (37)

1. Full LE, Ruisanchez C, Monaco C, (2009) The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther 11: 217.
2. Bartoloni E, Shoenfeld Y, Gerli R, (2011) Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin. Arthritis Care Res (Hoboken) 63: 178-183.
3. Dessein PH, Joffe BI, Veller MG, Stevens BA, Tobias M, et al. (2005) Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 32: 435-442.
4. González-Gay MA, González-Juanatey C, Martin J, (2005) Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 35: 8-17.
5. González-Gay MA, González-Juanatey C, López-Diaz MJ, Pineiro A, García-Porrua C, et al. (2007) HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 57: 125-132.
6. Mattey DL, Thomson W, Ollier WE, Batley M, Davies PG, et al. (2007) Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: results of eighteen years of followup from the early rheumatoid arthritis study. Arthritis Rheum 56: 1408-1416.
7. Palomino-Morales R, González-Juanatey C, Vazquez-Rodríguez TR, Rodríguez L, Miranda-Filloy JA, et al. (2010) A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis. Arthritis Res Ther 12: R71.
8. Rodríguez-Rodríguez L, González-Juanatey C, Palomino-Morales R, Vazquez-Rodríguez TR, Miranda-Filloy JA, et al. (2011) TNFA-308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis 216: 125-130.
9. Rodríguez-Rodríguez L, González-Juanatey C, García-Bermúdez M, Vazquez-Rodríguez TR, Miranda-Filloy JA, et al. (2011) CCR5Delta32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study. Arthritis Res Ther 13: R133.
10. López-Mejias R, García-Bermúdez M, González-Juanatey C, Castañeda S, Miranda-Filloy JA, et al. (2012) NFKB1-94ATTG ins/del polymorphism (rs28362491) is associated with cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis.
11. Firestein GS, (2005) Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. J Clin Rheumatol 11: S39-44.
12. Baccala R, Kono DH, Theofilopoulos AN, (2005) Interferons as pathogenic effectors in autoimmunity. Immunol Rev 204: 9-26.
13. Pokorny V, McLean L, McQueen F, Abu-Maree M, Yeoman S, (2001) Interferon-gamma microsatellite and rheumatoid arthritis. Lancet 358: 122-123.
14. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV, (2000) A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 61: 863-866.
15. Khani-Hanjani A, Lacaille D, Hoar D, Chalmers A, Horsman D, et al. (2000) Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis. Lancet 356: 820-825.
16. Constantin A, Navaux F, Lauwers-Cances V, Abbal M, van Meerwijk JP, et al. (2001) Interferon gamma gene polymorphism and susceptibility to, and severity of, rheumatoid arthritis. Lancet 358: 2051-2052.
17. Kim K, Cho SK, Sestak A, Namjou B, Kang C, et al. (2010) Interferon-gamma gene polymorphisms associated with susceptibility to systemic lupus erythematosus. Ann Rheum Dis 69: 1247-1250.
18. Vandenbroeck K, Cunningham S, Goris A, Alloza I, Heggarty S, et al. (2003) Polymorphisms in the interferon-gamma/interleukin-26 gene region contribute to sex bias in susceptibility to rheumatoid arthritis. Arthritis Rheum 48: 2773-2778.
19. Silverberg MS, Cho JH, Rioux JD, McGovern DP, Wu J, et al. (2009) Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 41: 216-220.
20. Schroecksnadel K, Frick B, Winkler C, Fuchs D, (2006) Crucial role of interferon-gamma and stimulated macrophages in cardiovascular disease. Curr Vasc Pharmacol 4: 205-213.
21. Hansson GK, Libby P, (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6: 508-519.
22. Patel S, Celermajer DS, Bao S, (2008) Atherosclerosis-underlying inflammatory mechanisms and clinical implications. Int J Biochem Cell Biol 40: 576-580.
23. Libby P, (2008) Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 121: S21-31.
24. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324.
25. González-Juanatey C, Llorca J, Martin J, González-Gay MA, (2009) Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum 38: 366-371.
26. González-Gay MA, González-Juanatey C, Vazquez-Rodríguez TR, Martin J, Llorca J, (2008) Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis. Semin Arthritis Rheum 38: 67-70.
27. González-Juanatey C, Testa A, García-Castelo A, García-Porrua C, Llorca J, et al. (2003) HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med 114: 647-652.
28. Skol AD, Scott LJ, Abecasis GR, Boehnke M, (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38: 209-213.
29. Carmona L, Villaverde V, Hernandez-García C, Ballina J, Gabriel R, et al. (2002) The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology (Oxford) 41: 88-95.
30. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, et al. (2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52: 402-411.
31. Amezcua-Guerra LM, Marquez-Velasco R, Hernandez-Avalos R, Vargas A, Bojalil R, (2008) Interferon-gamma is associated with vascular endothelial dysfunction in patients with rheumatoid arthritis. J Rheumatol 35: 2071-2074.
32. Kerekes G, Szekanecz Z, Der H, Sandor Z, Lakos G, et al. (2008) Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol 35: 398-406.
33. Aravena O, Pesce B, Soto L, Orrego N, Sabugo F, et al. (2011) Anti-TNF therapy in patients with rheumatoid arthritis decreases Th1 and Th17 cell populations and expands IFN-gamma-producing NK cell and regulatory T cell subsets. Immunobiology 216: 1256-1263.
34. Adamopoulos S, Kolokathis F, Gkouziouta A, Georgiadou P, Chaidaroglou A, et al. (2011) Cytokine gene polymorphisms are associated with markers of disease severity and prognosis in patients with idiopathic dilated cardiomyopathy. Cytokine 54: 68-73.
35. Gerli R, Schillaci G, Giordano A, Bocci EB, Bistoni O, et al. (2004) CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 109: 2744-2748.
36. Dhawan SS, Quyyumi AA, (2008) Rheumatoid arthritis and cardiovascular disease. Curr Atheroscler Rep 10: 128-133.
37. Harvey EJ, Ramji DP, (2005) Interferon-gamma and atherosclerosis: pro- or anti-atherogenic? Cardiovasc Res 67: 11-20.